# Glimepiride Induced Insulin Secretion Will be Inhibited by Hypoglycemia

> **NCT00608179** · NA · COMPLETED · sponsor: **Vanderbilt University** · enrollment: 32 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** Glimepiride
- **DRUG:** glyburide
- **OTHER:** glucose clamp
- **OTHER:** glucose clamp

## Key facts

- **NCT ID:** NCT00608179
- **Lead sponsor:** Vanderbilt University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-08
- **Primary completion:** 2004-09
- **Final completion:** 2010-12
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2014-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00608179

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00608179, "Glimepiride Induced Insulin Secretion Will be Inhibited by Hypoglycemia". Retrieved via AI Analytics 2026-07-29 from https://api.ai-analytics.org/clinical/NCT00608179. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*